NCT06674668 Effect of Vibrotactile Stimulation in Lateral Epicondylitis
| NCT ID | NCT06674668 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medipol University |
| Condition | Lateral Epicondylitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 33 participants |
| Start Date | 2023-06-14 |
| Primary Completion | 2024-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 33 participants in total. It began in 2023-06-14 with a primary completion date of 2024-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is aimed to investigate the immediate effect of vibrotactile stimulation on pain, sense and functionality in patients with lateral epicondylitis.
Eligibility Criteria
Inclusion Criteria: * Being between 18-65 years of age * Patients diagnosed with lateral epicondylitis Exclusion Criteria: * Having had elbow surgery * Having a history of congenital or acquired orthopedic, neurological, or rheumatological conditions affecting the upper limb * Having received any conservative treatment for the diagnosis of lateral epicondylitis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06674668 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Lateral Epicondylitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06674668 currently recruiting?
Yes, NCT06674668 is actively recruiting participants. Contact the research team at i.nas@iku.edu.tr for enrollment information.
Where is the NCT06674668 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06674668 clinical trial?
NCT06674668 is sponsored by Medipol University. The trial plans to enroll 33 participants.